Global markets for asthma and COPD drugs to grow to $47.1 billion in 2017

The global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is projected to reach $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 4.4%.

Learn about the industry structure, competitive aspects, current developments, and future trends in the market and identify areas of commercial interest. Company profiles and a patent review are also included in this report...

Use this report to:

• Analyze industry structure as well as competition within, including tiers of competition, regulatory aspects, and competitive factors
• Assess market needs, challenges, and trends
• Forecast overall market revenue and current market shares, as well as forecast by major drug class, disease indication, and geographical region
• Review and analyze compounds in clinical trials with an emphasis on drugs in advanced stages of development.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

SUMMARY FIGURE
GLOBAL MARKET FOR ASTHMA AND COPD PRESCRIPTION DRUGS BY REGION, 2012 AND 2017
(%)

 
Source: BCC Research